NEW YORK, NY / ACCESSWIRE / August 23, 2017 / U.S. markets surged Tuesday, with the Dow Jones Industrial Average posting its best daily gain since April, on renewed hopes for tax reform. The Dow Jones spiked 0.90 percent, 196.14 points, to close at 21,899.89, while the S&P 500 Index jumped 0.99 percent to close at 2,45.51. The NASDAQ Composite Index gained 1.36 percent to close at 6,297.48. The markets received a boost from a Politico reports stating that the Trump administration and key lawmakers were making progress on a tax reform plan. Investors are now looking ahead to the Kansas City Federal Reserve Bank's central bank symposium in Jackson Hole, Wyoming on Thursday.

"The conference has in recent years been a venue for big news in monetary policy, but this time around it is likely to be undramatic," wrote UBS economists in a note.

"We expect [Yellen's] speech to keep to well-trod financial stability topics?some excesses may exist, but the system is safe?and eschew discussion of potential near-term policy actions," they said.

RDI Initiates Coverage on:

Ionis Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=IONS

EXACT Sciences Corporation
https://rdinvesting.com/news/?ticker=EXAS

Ionis Pharmaceuticals Inc.'s stock jumped 5.16% Tuesday, to close the day at $48.88. The stock recorded a trading volume of 975,494 shares, which was below its three months average volume of 1,244,620 shares. In the last year Ionis Pharmaceuticals Inc.'s shares have traded in a range of 24.58 - 60.01. The share price has gained 98.86% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $51.44 is greater than its 200-day moving average of $47.15. Shares of the company are trading at a Price to Earnings ratio of 235.00. Shares of Ionis Pharmaceuticals have gained approximately 2.2 percent year-to-date.

Access RDI's Ionis Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IONS

On Tuesday, shares in Exact Sciences Corporation recorded a trading volume of 1,629,407 shares, which was below the three months average volume of 2,527,500 shares. The stock ended the day 4.73% higher at 40.52. The share price has gained 210.50% from its 52 week low with a 52 week trading range of 13.05 - 42.18.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $38.15 is greater than its 200-day moving average of $29.85. Shares of EXACT Sciences have gained approximately 203.29 percent year-to-date.

Access RDI's EXACT Sciences Corporation Research Report at:
https://rdinvesting.com/news/?ticker=EXAS

Our Actionable Research on Ionis Pharmaceuticals Inc. (NASDAQ:IONS) and Exact Sciences Corporation (NASDAQ:EXAS) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com